Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 7,740 shares at $70.41 ($556K) on 2022-03-04, disclosed to the SEC on 2022-03-07.
Seasonal sale ($556k) by Chief Operating Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.50 | 1,301 | $97K | 17.4% |
| 2 | $74.50 | 1,301 | $97K | 17.4% |
| 3 | $70.41 | 2,569 | $181K | 32.6% |
| 4 | $70.41 | 2,569 | $181K | 32.6% |
| Total | $71.78 avg | 7,740 | $556K | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |